GUFIC BIOSCIENCES LTD. - 509079 - Disclosure Of Related Party Transactions Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed disclosure of Related Party Transactions of the Company in the prescribed format for the half year ended September 30, 2022. GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
This is in continuation to our communication dated November 14, 2022 on Earnings Conference Call and pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, written transcript of the said call held on November 14, 2022 at 4:30 p.m., is enclosed herewith and has also been uploaded on the Company's website which can be accessed through the link: http://gufic.com/Notice/Written%20Transcript%20141122.pdf GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Audio Call Recording of the Earnings Conference Call held on November 14, 2022 at 4:30 p.m. has been uploaded on the Company's website and can be accessed through the link: http://gufic.com/Notice/AUDIORECORDING_14112022.mp3 Written transcript of the same will be submitted in due course. GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Investor Presentation on Un-Audited Financial Results for the quarter and half year ended September 30, 2022. GUFIC BIOSCIENCES LTD. - 509079 - Board Meeting Outcome for Meeting Held On Friday, November 11, 2022
Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') (including any statutory modification(s), amendment(s) and re-enactment(s) thereof), this is to inform you that the Board of Directors of the Company at its Meeting held today i.e. Friday, November 11, 2022, inter alia, considered and approved the Un-Audited Financial Results for the quarter and half year ended September 30, 2022. In this regard, we are enclosing herewith the following: 1. Un-Audited Financial Results for the Quarter and Half Year ended September 30, 2022 2. Limited Review Report received from the Statutory Auditor of the Company on the Un-Audited Financial Results for the Quarter and Half Year ended September 30, 2022. 3. Investor Presentation on the Financial Results. The meeting of the Board of Directors commenced at 3:00 p.m. and concluded at 7:10 p.m. GUFIC BIOSCIENCES LTD. - 509079 - Results- Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2022
Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') (including any statutory modification(s), amendment(s) and re-enactment(s) thereof), this is to inform you that the Board of Directors of the Company at its Meeting held today i.e. Friday, November 11, 2022, inter alia, considered and approved the Un-Audited Financial Results for the quarter and half year ended September 30, 2022. In this regard, we are enclosing herewith the following: 1. Un-Audited Financial Results for the Quarter and Half Year ended September 30, 2022 2. Limited Review Report received from the Statutory Auditor of the Company on the Un-Audited Financial Results for the Quarter and Half Year ended September 30, 2022. 3. Investor Presentation on the Financial Results. The meeting of the Board of Directors commenced at 3:00 p.m. and concluded at 7:10 p.m. GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform that the Company will host an Earnings Conference Call for Investors/Analysts on Monday, November 14, 2022, at 4:30 p.m. (IST), during which officials of the Company will discuss the business background/ prospects and financial performance of the Company and take questions. The details of the Earnings Conference Call are mentioned in the Call Invite enclosed herewith. GUFIC BIOSCIENCES LTD. - 509079 - Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2022
GUFIC BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2022 ,inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2022. Further in continuation to our disclosure on Closure of Trading Window dated September 29, 2022 and pursuant to the Company's Code of Conduct for Prevention of Insider Trading framed in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, the trading window in respect of dealing in the Equity Shares of the Company for all the Designated Persons of the Company along with their immediate relatives, shall continue to remain closed until 48 hours post declaration of the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2022. GUFIC BIOSCIENCES LTD. - 509079 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, please find enclosed herewith the letter received from M/s. Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of the Company for the quarter ended September 30, 2022. GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Credit Rating
Pursuant to Regulation 30 and other applicable provisions of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that M/s. CRISIL Ratings Limited, a credit rating agency, have reaffirmed its rating on various bank facilities availed by the Company, the details of which is attached herewith.